Mobile Site ›
Utilization Management 2013: A practical approach for pathology and clinical laboratory test utilization

Utilization Management 2013

A practical approach for pathology and clinical laboratory test utilization



October 8, 2013
The Loews Atlanta Hotel
Atlanta, Georgia

Curtis Hanson, MD Curtis Hanson, MD — Course Director
Consultant, Division of Hematopathology
Department of Laboratory Medicine and Pathology
Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic, Rochester, MN
+
Bobbi Pritt, MD Bobbi S. Pritt, MD — Course Director
Consultant, Division of Clinical Microbiology
Department of Laboratory Medicine and Pathology
Associate Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic, Rochester, MN
+
Don Flott Don Flott – Course Director
Director of Learning and Development and Marketing Education
Mayo Collaborative Services, LLC., Rochester, MN

+
Mike Astion, MD, PhD Mike Astion, MD, PhD
Division Chief, Laboratory Medicine
Seattle Children’s Hospital
Seattle, WA

+
James Hernandez, MD James Hernandez, MD
Medical Director and Chair, Division of Laboratory Medicine
Associate Professor of Laboratory Medicine and Pathology
Mayo Clinic in Arizona
Scottsdale and Phoenix, AZ

+
Brad Karon, MD, PhD Brad Karon, MD, PhD
Consultant, Division of Clinical Core Laboratory Services
Department of Laboratory Medicine and Pathology
Associate Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic, Rochester, MN

+
Mike Snyder Mike Snyder
Principal
Clinical Lab Business Solutions
Flemington, NJ

+
Mike Snyder James Stubbs, MD
Chair, Division of Transfusion Medicine
Assistant Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic, Rochester, MN

+

Faculty Disclosure

As a provider accredited by ACCME, College of Medicine, Mayo Clinic (Mayo School of Continuous Professional Development) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.


Key